Second, our study demonstrated that subjects with IGM had both reduced beta-cell function and decreased insulin sensitivity, which confirms previous reports of a decline in pancreatic beta-cell function in prediabetes [2,9,20]. This evidence concerns the gene INS and prediabetes syndrome.